Management of early diabetic nephropathy in adolescents with type 1 diabetes mellitus

Practical Diabetes International

Volumn 22, Issue 2, 2005, Pages 65-69

  Schwarze, C P ^a   Dunger, David B ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Adolescence; Diabetic nephropathy; Microalbuminuria; Type 1 diabetes

Indexed keywords

ALBUMIN; ANGIOTENSIN RECEPTOR ANTAGONIST; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; HEMOGLOBIN A1C; INSULIN; METOPROLOL; PLACEBO;

ADOLESCENT; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONSENSUS; DIABETIC NEPHROPATHY; DIARRHEA; DISEASE ASSOCIATION; DISEASE CONTROL; DISEASE COURSE; DISEASE DURATION; DRUG SAFETY; GLOMERULUS FILTRATION RATE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MEDICAL DECISION MAKING; META ANALYSIS; MICROALBUMINURIA; MORBIDITY; MORTALITY; PATIENT CARE; PREDICTION; PROTEIN RESTRICTION; PUBERTY; REMISSION; REVIEW; RISK ASSESSMENT; SEX DIFFERENCE; SMOKING CESSATION; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

EID: 16344371093     PISSN: 13578170     EISSN: None     Source Type: Journal    
DOI: 10.1002/pdi.754     Document Type: Review

References (66)

1. Andersen AR, Christiansen JS, Andersen JK, et al. Diabetic nephropathy in Type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia 1983; 25(6): 496-501.
2. Borch-Johnsen K, Andersen PK, Deckert T. The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1985; 28(8): 590-596.
3. Rossing P, Hougaard P, Borch-Johnsen K, et al. Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study. BMJ 1996; 313(7060): 779-784.
4. Parving HH, Hommel E. Prognosis in diabetic nephropathy. BMJ 1989; 299(6693): 230-233.
5. Borch-Johnsen K, Nissen H, Salling N, et al. The natural history of insulin-dependent diabetes in Denmark: 2. Long-term survival - who and why. Diabetic Med 1987; 4(3): 211-216.
6. Bojestig M, Arnqvist HJ, Hermansson G, et al. Declining incidence of nephropathy in insulin-dependent diabetes mellitus. N Engl J Med 1994; 330: 15-18.
7. Hovind P, Tarnow L, Rossing K, et al. Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes. Diabetes Care 2003; 26: 1258-1264.
8. Dunn BR, Anderson S, Brenner BM. The hemodynamic basis of progressive renal disease. Semin Nephrol 1986; 6: 122-138.
9. Mogensen CE, Andersen MJ. Increased kidney size and glomerular filtration rate in early juvenile diabetes. Diabetes 1973; 22: 706-712.
10. Gross JL, de Azevedo MJ, Silveiro SP, et al. Diabetic nephropathy: diagnosis, prevention and treatment. Diabetes Care 2005; 28: 164-176.
11. Schultz CJ, Konopelska-Bahu T, Dalton RN, et al; for the Oxford Regional Prospective Study Group. Microalbuminuria prevalence varies with age, sex and puberty in children with insulin dependent mellitus followed in a longitudinal study from diagnosis. Diabetes Care 1999; 22: 495-502.
12. Berg UB, Torbjornsdotter TB, Jaremko G, et al. Kidney morphological changes in relation to long-term renal function and metabolic control in adolescents with IDDM. Diabetologia 1998; 41(9): 1047-1056.
13. Bangstad HJ, Osterby R, Dahl-Jorgensen K, et al. Early glomerulopathy is present in young, type 1 (insulin-dependent) diabetic patients with microalbuminuria. Diabetologia 1993; 36(6): 523-529.
14. Osterby R, Hartmann A, Nyengaard JR, et al. Development of renal structural lesions in type-1 diabetic patients with microalbuminuria. Observations by light microscopy in 8-year follow-up biopsies. Virchows Arch 2002; 440(1): 94-101.
15. Caramori ML, Kim Y, Huang C, et al. Cellular basis of diabetic nephropathy: 1. Study design and renal structural-functional relationships in patients with long-standing type 1 diabetes. Diabetes 2002; 51(2): 506-513.
16. Drummond K, Mauer M; International Diabetic Nephropathy Study Group. The early natural history of nephropathy in type 1 diabetes: II. Early renal structural changes in type 1 diabetes. Diabetes 2002; 51(5): 1580-1587.
17. Viberti GC, Jarrett RJ, Keen H. Microalbuminuria as prediction of nephropathy in diabetics. Lancet 1982; 2(8298): 611.
18. Mogensen CE, Christensen CK. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 1984; 311(2): 89-93.
19. Almdal T, Norgaard K, Feldt-Rasmussen B, et al. The predictive value of microalbuminuria in IDDM. A five-year follow-up study. Diabetes Care 1994; 17(2): 120-125.
20. Parving HH, Oxenboll B, Svendsen PA, et al. Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion. Acta Endocrinol (Copenh) 1982; 100(4): 550-555.
21. Mathiesen ER, Oxenboll B, Johansen K, et al. Incipient nephropathy in type 1 (insulin-dependent) diabetes. Diabetologia 1984; 26(6): 406-410.
22. Earle K, Walker J, Hill C, et al. Familial clustering of cardiovascular disease in patients with insulin-dependent diabetes and nephropathy. N Engl J Med 1992; 326(10): 673-677.
23. Messent JW, Elliott TG, Hill RD, et al. Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: a twenty-three year follow-up study. Kidney Int 1992; 41(4): 836-839.
24. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 1984; 310(6): 356-360.
25. Stephenson JM, Kenny S, Stevens LK, et al. Proteinuria and mortality in diabetes: the WHO Multinational Study of Vascular Disease in Diabetes. Diabetic Med 1995; 12(2): 149-155.
26. American Diabetes Association. Diabetic Nephropathy. Diabetes Care 2003; 26(Suppl 1): S94-S98.
27. American Diabetes Association. Implications of the Diabetes Control and Complications Trial. Diabetes Care 2003; 26(Suppl 1): S25-S27.
28. American Diabetes Association. Standards of Medical Care for Patients with Diabetes Mellitus. Diabetes Care 2003; 26(Suppl 1): S33-S50.
29. Lewis EJ, Hunsicker LG, Bain RP, et al, The Collaborative Study Group. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 1993; 329: 1456-1462.
30. Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. The EUCLID Study Group. Lancet 1997; 349: 1787-1792.
31. Gilbert RE, Tsalamandris C, Bach LA, et al. Long-term glycemic control and the rate of progression of early diabetic kidney disease. Kidney Int 1993; 44(4): 855-859.
32. Schultz CJ, Neil HA, Dalton RN, et al.; Oxford Regional Prospective Study Group. Risk of nephropathy can be detected before the onset of microalbuminuria during the early years after diagnosis of type 1 diabetes. Diabetes Care 2000; 23(12): 1811-1815.
33. Danne T, Kordonouri O. Controversies on the pathogenesis of diabetic angiopathy: which treatment for normotensive adolescents with microalbuminuria and type 1 diabetes? J Pediatr Endocrinol Metab 1998; 11(Suppl 2): 347-363.
34. Chiarelli F, Trotta D, Verrotti A, et al. Treatment of hypertension in children and adolescents with type 1 diabetes mellitus. Pediatr Diabetes 2002; 3: 113-124.
35. Couper JJ, Clarke CF, Byrne GC, et al. Progression of borderline increases in albuminuria in adolescents with insulin-dependent diabetes mellitus. Diabetic Med 1997; 14(9): 766-771.
36. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993; 329: 977-986.
37. The absence of glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial. Diabetes 1996; 45(10): 1289-1298.
38. Walker JD, Close CF, Jones SL, et al. Glomerular structure in type-1 (insulin-dependent) diabetic patients with normo- and microalbuminuria. Kidney Int 1992; 41(4): 741-748.
39. Amin R, Schultz C, Ong K, et al; Oxford Regional Prospective Study. Low IGF-I and elevated testosterone during puberty in subjects with type 1 diabetes developing microalbuminuria in comparison to normoalbuminuric control subjects: The Oxford Regional Prospective Study. Diabetes Care 2003; 26(5): 1456-1461.
40. Amin R, Williams RM, Frystyk J, et al. Increasing urine albumin excretion is associated with growth hormone hypersecretion and reduced clearance of insulin in adolescents and young adults with type 1 diabetes: the Oxford Regional Prospective Study. Clin Endocrinol 2005; 62(2): 137-144.
41. Lurbe A, Redon J, Pascual JM, et al. Altered blood pressure during sleep in normotensive subjects with type I diabetes. Hypertension 1993; 21(2): 227-235.
42. Lurbe E, Thijs L, Redon J, et al. Diurnal blood pressure curve in children and adolescents. J Hypertens 1996; 14 1): 41-46.
43. Holl RW, Pavlovic M, Heinze E, et al. Circadian blood pressure during the early course of type I diabetes. Analysis of 1,011 ambulatory blood pressure recordings in 354 adolescents and young adults. Diabetes Care 1999; 22: 1151-1157.
44. Poulsen PL, Ebbehoj E, Hansen KW, et al. 24-h blood pressure and utonomic function is related to albumin excretion within the normoalbuminuric range in IDDM patients. Diabetologia 1997; 40 6): 718-725.
45. Sivieri R, Deandrea M, Gai V, et al. Circadian blood pressure levels in normotensive normoalbuminuric type 1 diabetic patients. Diabetic Med 1994; 11(4): 357-361.
46. Pecis M, Azevedo MJ, Gross JL. Glomerular hyperfiltration is associated with blood pressure abnormalities in normotensive normoalbuminuric IDDM patients. Diabetes Care 1997; 20(8): 1329-1333.
47. Lurbe E, Redon J, Pascual JM, et al. The spectrum of circadian blood pressure changes in type I diabetic patients. J Hypertens 2001; 19(8): 1421-1428.
48. Lurbe E, Redon J, Kesani A, et al. Increase in nocturnal blood pressure and progression to microalbuminuria in type I diabetes. N Engl J Med 2002; 347(11): 797-805.
49. Torbjornsdotter TB, Jaremko GA, Berg UB. Nondipping and its relation to glomerulopathy and hyperfiltration in adolescents with type I diabetes. Diabetes Care 2004; 27(2): 510-516.
50. Chase HP, Garg SK, Marshall G, et al. Cigarette smoking increases the risk of albuminuria among subjects with type I diabetes. JAMA 1991; 265(5): 614-617.
51. Sawicki PT, Didjurgeit U, Muhlhauser I, et al. Smoking is associated with progression of diabetic nephropathy. Diabetes Care 1994; 17(2): 126-131.
52. Seaquist ER, Goetz FC, Rich S, et al. Familial clustering of diabteic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 1989; 320 18): 1161-1165.
53. Fagerudd JA, Pattersson-Fernholm KJ, Gronhagen-Riska C, et al. The impact of family history of type II (non-insulin-dependent) diabetes mellitus on the risk of diabetic nephropathy in patients with type I (insulin-dependent) diabetes mellitus. Diabetologia 1999; 42(5): 519-526.
54. Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. The Diabetes Control and Complications (DCCT) Research Group. Kidney Int 1995; 47(6): 1703-1720.
55. Bangstad HJ, Osterby R, Dahl-Jorgensen K, et al. Improvement of blood glucose control in IDDM patients retards the progression of morphological changes in early diabetic nephropathy. Diabetologia 1994; 37(5): 483-490.
56. Pedrini MT, Levey AS, Lau J, et al. The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal disease: a meta-analysis. Ann Int Med 1996; 124(7): 627-632.
57. Toeller M, Buyken A, Heitkamp G, et al. Protein intake and urinary albumin excretion rates in the EURODIAB IDDM Complications Study. Diabetologia 1997; 40(10): 1219-1226.
58. ACE Inhibitors in Diabetic Nephropathy Trialist Group. Should all patients with type I diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta-analysis of individual patient data. Ann Intern Med 2001; 134(45): 370-379.
59. O'Hare P, Bilbous R, Mitchell T, et al.; ACE-Inhibitor trial to lower albuminuria in normotensive insulin-dependent subjects study group. Low-dose ramipril reduces microalbuminuria in type 1 diabetic patients without hypertension: results of a randomised controlled trial. Diabetes Care 2000; 23(12): 1823-1829.
60. Ahmad J, Shafique S, Abidi SM, et al. Effect of 5-year enalapril therapy on progression of microalbuminuria and glomerular structural changes in type I diabetic subjects. Diabetes Res Clin Pract 2003; 60(2): 131-138.
61. Laverman GD, Remuzzi G, Ruggenenti P. ACE inhibition versus angiotensin receptor blockade: which is better for renal and cardiovascular protection? J Am Soc Nephrol 2004; 15(Suppl 1): S64-S70.
62. Cook J, Daneman D, Spino M, et al. Angiotensin converting enzyme inhibitor therapy to decrease microalbuminuria in normotensive children with insulin-dependent diabetes mellitus. J Pediatr 1990; 117: 39-45.
63. Rudberg S, Aperia A, Freyschuss U, et al. Enalapril reduces microalbuminuria in young normotensive type I (insulin-dependent) diabetic patients irrespective of its hypotensive effect. Diabetologia 1990; 33(8): 470-476.
64. Yuksel H, Darcan S, Kabasakal C, et al. Effect of enalapril on proteinuria, phosphaturia, and calciuria in insulin-dependent diabetes. Pediatr Nephrol 1998; 12(8): 648-650.
65. Rudberg S, Osterby R, Bangstad HJ, et al. Effect of angiotensin converting enzyme inhibitor or beta blocker on glomerular structural changes in young microalbuminuric patients with type I (insulin-dependent) diabetes mellitus. Diabetologia 1999; 42 5): 589-595.
66. Mirkin BL, Newman TJ. Efficacy and safety of captopril in the treatment of severe childhood hypertension: report of the International Collaborative Study Group. Pediatrics 1985; 75(6): 1091-1100.